Brainstorm Health: Biotech R&D, Tobacco 21, Criminal Opioid Case
Big pharma companies are in an ROI rut. But that doesn’t mean drug developers at large are grappling with a midlife crisis. In fact, the young guns of the industry—upstart biotechs—aren’t doing too shabby, according to a new Iqvia Institute report. There have been a few notable shifts in drug development ... Read More »